2-(2-METHOXYPHENYL)-2-(MORPHOLIN-4-YL)ACETONITRILE, 90.0%, 2g

2-Fluoro-4-methyl-3-(trifluoromethyl)phenylacetonitrile, 1g

5-Bromo-2-furanamide, 95.0%, 1g

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 5mg

Methyl 3-Amino-4-nitrobenzoate, 95.0%, 1g

Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate, 95.0%, 50mg

Chlorodifluoroacetic Anhydride>98.0%(T)10g

N-METHYL-4-(6-PHENYLIMIDAZO[1,2-A]PYRAZIN-3-YL)BENZAMIDE, 95%, 5mg

3-(4-methylphenyl)-6-(piperazin-1-yl)pyridazine, 95.0%, 2g

5-Amino-2-bromobenzotrifluoride, 98.0%, 500g

(3-((4-Methylpiperidin-1-yl)methyl)phenyl)boronic acid, 98+%, 250mg

3-(5,5-dimethyl-5,6-dihydro[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)phenol, 95.0%, 5g

Triclorometano/cloroformo D1 con TMS, 99,8 átomo %D, stab. con Ag, 0,03 % en volumen TMS